REVVITY, INC Write off of Deferred Debt Issuance Cost
REVVITY, INC (RVTY) reported Write off of Deferred Debt Issuance Cost of $200.00 thousand for the 3-month period ending 2013-12-29, per its 10-K filed 2016-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2016-03-01
- REVVITY, INC write off of deferred debt issuance cost for the quarter ending 2013-12-29 was $200.00K.
- REVVITY, INC write off of deferred debt issuance cost for fiscal 2013 was $200.00K.
| Period end | Write off of Deferred Debt Issuance Cost 3 month | Write off of Deferred Debt Issuance Cost 12 month |
|---|---|---|
| 2013-12-29 | $200.00K 10-K · filed 2016-03-01 | $200.00K 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |